| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/29/1997 | US5624836 DNA encoding bovine pancreatic cholesterol esterase |
| 04/29/1997 | US5624832 β1 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity |
| 04/29/1997 | US5624823 DNA encoding procine interleukin-10 |
| 04/29/1997 | US5624821 Antibodies with altered effector functions |
| 04/29/1997 | US5624819 Dna, nucleic acid detectors, mutant genes and genetic engineering |
| 04/29/1997 | US5624807 Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms |
| 04/29/1997 | US5624806 Antibodies to cardiac hypertrophy factor and uses thereof |
| 04/29/1997 | US5624804 Glycosylation of protein such as albumin for medical diagnosis |
| 04/29/1997 | US5624801 Methods of identifying human osteoclast-specific and related genes |
| 04/29/1997 | US5624795 Isolation and characterization of a novel chimpanzee lentivirus, designated simian immunodeficiency virus isolate cpz-ant |
| 04/29/1997 | US5624659 Method of treating brain tumors expressing tenascin |
| 04/28/1997 | CA2188900A1 Gene of the hop latent virus and methods for detecting the same |
| 04/24/1997 | WO1997014813A1 A novel human b cell surface molecule |
| 04/24/1997 | WO1997014810A1 Use of procaryotic hosts for expression of gene in eucaryotic cells |
| 04/24/1997 | WO1997014802A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 04/24/1997 | WO1997014801A1 Novel cell surface protein compounds |
| 04/24/1997 | WO1997014800A1 Novel saliva binding protein |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014796A1 Monoclonal antibody br110 and uses thereof |
| 04/24/1997 | WO1997014795A1 Tumor associated polypeptides with carboxyl-terminal alanine-proline, proline-proline or glycine-proline and antibodies thereto |
| 04/24/1997 | WO1997014794A1 ACTIVATION OF p53 PROTEIN |
| 04/24/1997 | WO1997014719A1 A bifunctional or bivalent antibody fragment analogue |
| 04/24/1997 | WO1997014718A1 Monoclonal antibodies to potato, tomato and eggplant glycoalkaloids and assays for the same |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014437A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | WO1997014426A1 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/24/1997 | WO1996034107A3 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/24/1997 | WO1996027665A3 Neuron-restrictive silencer factor proteins |
| 04/24/1997 | CA2233848A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | CA2232235A1 A novel human b cell surface molecule |
| 04/23/1997 | EP0769696A2 Antibodies and proteins useful for assaying virus infection in grape plants |
| 04/23/1997 | EP0769149A1 Immunoassay for mycophenolic acid |
| 04/23/1997 | EP0769065A1 Methods for identifying inhibitors of integrin activation |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769052A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/23/1997 | EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768890A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 04/23/1997 | EP0493418B1 Method of producing fusion proteins |
| 04/23/1997 | EP0394418B1 Osteogenic factors |
| 04/23/1997 | EP0387276B1 Method to produce immunodiagnostic reagents |
| 04/23/1997 | CN1148408A Hematopoietic Protein and materials and method for making it |
| 04/23/1997 | CN1148343A Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 04/22/1997 | US5623058 Medical diagnosis; complexing using dimethylethylaminopropylcarbodiimide |
| 04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
| 04/22/1997 | US5622929 Anthracycline antibiotic; antitumor agent binds with a target cell |
| 04/22/1997 | US5622842 DNA encoding canine immunoglobulin A |
| 04/22/1997 | US5622839 Recombinant production of human calcitonin receptor polypeptides |
| 04/22/1997 | US5622837 Reacts with body fluid and stools |
| 04/22/1997 | US5622836 Monoclonal antibodies which recognize malignant cells from bladder carcinomas |
| 04/22/1997 | US5622835 WT1 monoclonal antibodies |
| 04/22/1997 | US5622702 Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | US5622700 Administering initial dosage of antibody, subsequent intermittent dosing |
| 04/22/1997 | CA2031265C Methods of detecting collagen degradation in vivo |
| 04/17/1997 | WO1997013852A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013785A1 Transferrin receptor protein of moraxella |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013522A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | WO1997003203A3 Generation of immune responses to prostate-specific antigen (psa) |
| 04/17/1997 | WO1997002346A3 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2234723A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2232813A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/16/1997 | EP0768379A1 Ubiquitous potassium-channel proteins and genes for the same |
| 04/16/1997 | EP0767914A1 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767676A1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 04/16/1997 | EP0767667A2 USE OF $g(b)GalNac(1-4)$g(b)Gal CONJUGATES TO TREAT CANDIDA INFECTION |
| 04/16/1997 | EP0722336A4 RECOMBINANT COFFEE BEAN -g(a)-GALACTOSIDASE |
| 04/16/1997 | EP0625912B1 Treatment for inflammatory bowel disease |
| 04/16/1997 | EP0514515B1 Anthracycline-conjugates |
| 04/16/1997 | EP0454782B1 Cancer related haptoglobin (hpr) |
| 04/16/1997 | CN1034576C Precursor protein of APC polypeptide, DNA coding for this, and diagnostic use of DNA and of protein |
| 04/15/1997 | US5621090 Nucleic acids encoding soluble human FLK-2 extracellular domain |
| 04/15/1997 | US5621083 Immunotoxins comprising ribosome-inactivating proteins |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621080 A glycoprotein, a polypeptide product, causes bone marrow cells to increase production of reticulocytes and red blood cells |
| 04/15/1997 | US5621079 Produced by culturing cell transformed by expression vector containing selected dna sequence |
| 04/15/1997 | US5621077 Genetic engineering |
| 04/15/1997 | US5621075 Insulin receptor substrate |
| 04/15/1997 | US5620956 Inhibiting differentiation of cytotoxic t-lymphocyte precursor to mature cell specific for foreign antigen |
| 04/15/1997 | US5620902 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 04/15/1997 | US5620890 Qualitative analysis |
| 04/15/1997 | US5620889 Human anti-Fas IgG1 monoclonal antibodies |
| 04/15/1997 | US5620867 Isolated dna molecule comprising nucelotide sequence encoding polypeptide having specified amino acid sequence |
| 04/15/1997 | US5620864 Acceptor for fucosyl transferase |
| 04/15/1997 | US5620861 Method and kit for pyridinium crosslink assay |
| 04/15/1997 | US5620856 Contacting antibody specific for endogenous peptide with sample of body fluid containing metallic cation to form complex, adding second antibody specific for epitope on complex to form second complex, determining amount formed |
| 04/15/1997 | US5620848 Methods for detecting mutant p53 |
| 04/15/1997 | US5620844 Assays for detecting hepatitis B virus envelope antigens or antibodies thereto and diagnostic test kits for use in performing the assays |